Clovis Oncology
CLVS
#10878
Rank
โ‚น1.09 B
Marketcap
โ‚น7.55
Share price
0.00%
Change (1 day)
-94.83%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -โ‚น16.87 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are โ‚น0.13 Billion. In 2021 the company made an earning of -โ‚น21.7 Billion, an increase over its 2020 earnings that were of -โ‚น32.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚น16.87 Billion-22.28%
2021 -โ‚น21.7 Billion-32.64%
2020 -โ‚น32.22 Billion-9.06%
2019 -โ‚น35.43 Billion7.49%
2018 -โ‚น32.96 Billion4.42%
2017 -โ‚น31.56 Billion-8.83%
2016 -โ‚น34.62 Billion-0.4%
2015 -โ‚น34.76 Billion140.82%
2014 -โ‚น14.44 Billion86.64%
2013 -โ‚น7.74 Billion19.53%
2012 -โ‚น6.47 Billion
2010 -โ‚น2.48 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.741 T-8,711.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น648.23 B-3,305.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น1.192 T-5,994.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.234 T-16,092.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.403 T-7,040.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
โ‚น4.06 B-120.08%๐Ÿ‡บ๐Ÿ‡ธ USA